Mortality risk of small infants varies with their mother's birthweight and race

Albert K Owusu-Ansah1, Richard J David

  • 1Division of Neonatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL 60612, USA.

We analysed a transgenerational linked birth file to investigate the relationship between maternal birthweight and infant birthweight-specific mortality risk for white and African American infants. Birth records of 267,303 infants born between 1989 and 1991 were linked to records of their mothers, born between 1956 and 1976, and to their own death certificates for those dying in the first year. The means, standard deviations and z-scores were calculated for each race- and generation-specific birthweight distribution. Investigators then analysed the mortality of very small infants (birthweight at least two standard deviations below their mean) for three maternal birthweight categories. Over half of the infant deaths involved births with weights more than two standard deviations below the relevant population mean birthweight (comprising 4.2% of white and 6.9% of African American births respectively). African American infants experienced higher mortality rates at all levels of standardised birthweight, from z-scores of -3 to +3. The relative risk of mortality associated with very small infant size was less for infants delivered to smaller birthweight mothers when compared with those whose mothers were average sized or large at birth. This differential effect was confined to neonatal deaths and was more prominent in the white subpopulation.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...